title: Pharmacologic treatment of congenital nystagmus.
authors.affiliation: Department of Ophthalmology, Faculty of Medicine and Biological Sciences, The Leicester Royal Infirmary, England. nagini@pathmanathan.com
authors.forename: N
authors.initials: N
authors.lastname: Sarvananthan
authors.forename: F A
authors.initials: FA
authors.lastname: Proudlock
authors.forename: I
authors.initials: I
authors.lastname: Choudhuri
authors.forename: H
authors.initials: H
authors.lastname: Dua
authors.forename: I
authors.initials: I
authors.lastname: Gottlob
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005133:Eye Movements; D000077206:Gabapentin; D006801:Humans; D008297:Male; D020417:Nystagmus, Congenital / Q000188:drug therapy*; D014792:Visual Acuity; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin